PCI Biotech focuses on localised cancer therapy with minimum side effects
 

Side effects are currently the biggest problem with any cancer treatment. A Norwegian biotech company is drawing closer to the goal of creating a treatment which kills only cancer cells, leaving other cells unaffected.

More...